Cibus (NASDAQ:CBUS) Earns Buy Rating from HC Wainwright

Cibus (NASDAQ:CBUS)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $25.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 373.48% from the company’s current price.

CBUS has been the subject of several other research reports. Alliance Global Partners dropped their price target on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research report on Tuesday, September 24th. Canaccord Genuity Group upgraded Cibus to a “strong-buy” rating in a report on Friday, July 19th. Finally, Canaccord Genuity Group restated a “buy” rating and set a $20.00 price target on shares of Cibus in a report on Tuesday, October 22nd.

Cibus Stock Performance

Shares of CBUS opened at $5.28 on Monday. The stock has a market capitalization of $121.91 million, a PE ratio of -0.23 and a beta of 1.79. The company’s fifty day moving average is $4.08 and its 200 day moving average is $8.79. Cibus has a fifty-two week low of $2.86 and a fifty-two week high of $23.18.

Cibus (NASDAQ:CBUS) last posted its earnings results on Thursday, August 8th. The company reported ($1.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.81) by ($0.33). The business had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.44 million. Cibus had a negative return on equity of 29.05% and a negative net margin of 9,856.84%. During the same quarter last year, the firm earned ($3.05) earnings per share. As a group, research analysts forecast that Cibus will post -3.84 earnings per share for the current year.

Institutional Trading of Cibus

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Old West Investment Management LLC increased its stake in Cibus by 3.6% in the second quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock worth $524,000 after purchasing an additional 1,868 shares during the period. FineMark National Bank & Trust grew its holdings in shares of Cibus by 24.3% in the second quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock worth $202,000 after purchasing an additional 4,000 shares during the last quarter. SG Americas Securities LLC purchased a new position in Cibus in the 3rd quarter worth about $33,000. Squarepoint Ops LLC bought a new stake in Cibus during the 2nd quarter valued at about $214,000. Finally, Rhumbline Advisers purchased a new stake in Cibus in the 2nd quarter valued at about $221,000. 33.81% of the stock is owned by hedge funds and other institutional investors.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.